AI & Tech Brief — June 24, 2026
OpenAI's GPT-5 helped crack a three-year immunology puzzle that could accelerate cancer and autoimmune research, while the company pushes global AI safety standards [1][2]. Meanwhile, memory chip makers face pressure from Chinese competitors, and travel platform Omio shows how conversational AI is reshaping real-world business [3][4].
Read full analysis →